Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?
- 19 October 2009
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 31 (1) , 32-38
- https://doi.org/10.1016/j.it.2009.09.005
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptidesBiomaterials, 2009
- Complement activation triggered by chondroitin sulfate released by thrombin receptor‐activated plateletsJournal of Thrombosis and Haemostasis, 2008
- Dissecting the instant blood‐mediated inflammatory reaction in islet xenotransplantationXenotransplantation, 2008
- Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and functionJournal of Biomedical Materials Research Part A, 2008
- A New Method for Incorporating Functional Heparin onto the Surface of Islets of LangerhansTissue Engineering, Part C: Methods, 2008
- Acute Antibody-Mediated Complement Activation Mediates Lysis of Pancreatic Islets Cells and May Cause Tissue Loss in Clinical Islet TransplantationTransplantation, 2008
- The catastrophe revisited: Blood compatibility in the 21st CenturyPublished by Elsevier ,2007
- Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet TransplantationDiabetes, 2007
- A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine isletsSurgery, 2004
- Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation1Transplantation, 2003